Please scroll down for podcast, slides and transcript.

Please note there is no video available for this presentation.



Upon completion of the video presentation, to finish the activity and claim your credit, please click here.

This activity is supported by unrestricted educational grants from Celgene Corporation and Takeda Oncology.

Risk Stratification in Multiple Myeloma: Putting the Pieces Together

Hans Lee, MD
The University of Texas MD Anderson Cancer Center

Tiffany A. Richards, PhD, ANP, AOCNP®
The University of Texas MD Anderson Cancer Center

While the past few years have shown an unprecedented increase in the number of agents available to treat patients with multiple myeloma, many advanced practitioners struggle with optimal agent choice, timing, and sequencing, especially related to the use of these newer agents in combination regimens. Learn about these aspects of treatment, as well as testing and diagnosis, risk stratification, emerging toxicities, and supporting patients on oral therapies.



 

Download Podcast

   To claim credit for podcast click here
 
 

Download Transcript

 
 

Download Slides

 
 

Download Slides & Transcripts

   To claim credit for the slides & transcript click here





These CME/CE/CPE accredited activities are jointly provided by

JADPRO CE Logo Harborside Press Logo APSHO Logo Annenberg Logo
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.